Regulations.gov document
Attachment 2 Theravance Biopharma Medicines that make a difference® ATTAIN Studies…
Supporting & Related Material · FDA-2010-D-0589 · posted Jun 5, 2017
Key facts
| Document ID | FDA-2010-D-0589-0029 |
|---|---|
| Title | Attachment 2 Theravance Biopharma Medicines that make a difference® ATTAIN Studies Overview May 15, 2015 re: Comment from Foundation for the National Institutes of Health |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2010-D-0589 |
| Posted | Jun 5, 2017 |
At a glance
- None Pages
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: